Koji Hatano

5.7k total citations
259 papers, 3.4k citations indexed

About

Koji Hatano is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Koji Hatano has authored 259 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Pulmonary and Respiratory Medicine, 59 papers in Oncology and 58 papers in Molecular Biology. Recurrent topics in Koji Hatano's work include Sarcoma Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (28 papers) and Bladder and Urothelial Cancer Treatments (25 papers). Koji Hatano is often cited by papers focused on Sarcoma Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (28 papers) and Bladder and Urothelial Cancer Treatments (25 papers). Koji Hatano collaborates with scholars based in Japan, United States and Germany. Koji Hatano's co-authors include Norio Nonomura, Naoto Endo, Akira Ogose, Kazutoshi Fujita, Tetsuo Hotta, Hiroyuki Kawashima, Tetsuro Morita, Makoto Matsushita, Atsunari Kawashima and H Yamagiwa and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Koji Hatano

244 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koji Hatano Japan	33	1.3k	1.1k	758	639	534	259	3.4k
Mai P. Hoang United States	39	1.2k 0.9×	662 0.6×	2.0k 2.7×	782 1.2×	484 0.9×	207	4.8k
Shingo Miyamoto Japan	29	1.4k 1.1×	457 0.4×	888 1.2×	282 0.4×	534 1.0×	118	3.7k
Hidetoshi Okabe Japan	31	992 0.8×	626 0.6×	629 0.8×	776 1.2×	301 0.6×	217	3.2k
Robert Salomon United States	29	1.2k 1.0×	366 0.3×	432 0.6×	770 1.2×	275 0.5×	67	3.7k
Akihiro Watanabe Japan	30	654 0.5×	459 0.4×	541 0.7×	533 0.8×	152 0.3×	170	2.9k
Hiroyuki Nakanishi Japan	35	724 0.6×	1.1k 1.0×	480 0.6×	478 0.7×	422 0.8×	174	3.9k
Chang Jiang China	26	703 0.5×	474 0.4×	1.1k 1.4×	299 0.5×	511 1.0×	114	2.7k
Fei Huang China	35	3.2k 2.5×	711 0.7×	1.7k 2.2×	295 0.5×	1.5k 2.8×	190	6.5k
Andrea Onetti Muda Italy	32	1.4k 1.1×	335 0.3×	611 0.8×	784 1.2×	262 0.5×	153	3.9k
Chun‐Liang Chen Taiwan	37	1.7k 1.4×	1.8k 1.7×	1.7k 2.3×	607 0.9×	657 1.2×	139	5.1k

Countries citing papers authored by Koji Hatano

Since Specialization

Citations

This map shows the geographic impact of Koji Hatano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Hatano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Hatano more than expected).

Fields of papers citing papers by Koji Hatano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Hatano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Hatano. The network helps show where Koji Hatano may publish in the future.

Co-authorship network of co-authors of Koji Hatano

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Hatano. A scholar is included among the top collaborators of Koji Hatano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Hatano. Koji Hatano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ishizuya, Yu, Atsunari Kawashima, Yutong Liu, et al.. (2025). FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma. Scientific Reports. 15(1). 4640–4640. 1 indexed citations

Tsukushi, Satoshi, Kazuhiro Tanaka, Toshiyuki Kunisada, et al.. (2025). Clinicopathological background of local recurrence in high grade sarcoma of the extremity with preoperative chemotherapy: a supplementary analysis of JCOG0304. Japanese Journal of Clinical Oncology. 55(6). 603–609.

Yamamoto, Yoshiyuki, Atsunari Kawashima, Kosuke Nakano, et al.. (2025). Comparative Outcomes of Adjuvant Chemotherapy and Immunotherapy After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study. JU Open Plus. 3(11).

Yamamichi, Gaku, et al.. (2024). Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Anticancer Research. 44(3). 879–888. 2 indexed citations

Watabe, Tadashi, Koji Hatano, Sadahiro Naka, et al.. (2024). First-in-human SPECT/CT imaging of [211At]PSMA-5: targeted alpha therapy in a patient with refractory prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(7). 2253–2255. 10 indexed citations

Kawashima, Atsunari, Yu Ishizuya, Yoshiyuki Yamamoto, et al.. (2024). Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution. International Journal of Clinical Oncology. 29(8). 1096–1104. 4 indexed citations

Velasco, Marco A. De, Kazuko Sakai, Makoto Matsushita, et al.. (2024). A cross‐species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk. The Prostate. 84(15). 1375–1386. 1 indexed citations

Matsushita, Makoto, Kazutoshi Fujita, Daisuke Motooka, et al.. (2022). Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men. The World Journal of Men s Health. 40(3). 517–517. 34 indexed citations

Urakawa, Hiroshi, Akihito Nagano, Ryunosuke Machida, et al.. (2022). A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610. Japanese Journal of Clinical Oncology. 52(9). 1021–1028. 3 indexed citations

10.

Jingushi, Kentaro, Atsunari Kawashima, Takuro Saito, et al.. (2022). Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients. Cancer Immunology Immunotherapy. 71(12). 2999–3011. 10 indexed citations

11.

Hatano, Koji, Tohru Yoneyama, Shingo Hatakeyama, et al.. (2021). Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer. British Journal of Cancer. 126(5). 764–770. 17 indexed citations

12.

Takezawa, Kentaro, Kazutoshi Fujita, Makoto Matsushita, et al.. (2021). The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement. The Prostate. 81(16). 1287–1293. 50 indexed citations

13.

Hayashi, Takuji, Kazutoshi Fujita, Yujiro Hayashi, et al.. (2020). Mutational Landscape and Environmental Effects in Bladder Cancer. International Journal of Molecular Sciences. 21(17). 6072–6072. 31 indexed citations

14.

Yasui, Taku, Wataru Shioyama, Toru Oka, et al.. (2020). Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report. Cardio-Oncology. 6(1). 18–18.

15.

Zennami, Kenji, Su‐Mi Choi, Ying Li, et al.. (2018). PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance. Molecular Cancer Research. 17(2). 618–627. 30 indexed citations

16.

Kawashima, Hiroyuki, Akira Ogose, Tetsuo Hotta, et al.. (2018). Prognostic impact of the tumor immune microenvironment in synovial sarcoma. Cancer Science. 109(10). 3043–3054. 50 indexed citations

17.

Kumar, Binod, Koji Hatano, Luisa M. Russell, et al.. (2016). Development and Application of a Novel Model System to Study “Active” and “Passive” Tumor Targeting. Molecular Cancer Therapeutics. 15(10). 2541–2550. 10 indexed citations

18.

Ishizuya, Yu, Koji Hatano, Yasutomo Nakai, et al.. (2016). [A Case of Renal Cell Carcinoma with Malignant Pleural Effusion Showing Marked Response to Axitinib].. Kyoto University Research Information Repository (Kyoto University). 62(10). 525–528. 1 indexed citations

19.

Hatano, Koji, Motonari Nomura, Tomoyuki Nishikawa, et al.. (2012). TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles. Clinical Cancer Research. 18(22). 6271–6283. 79 indexed citations

20.

Hatano, Koji, et al.. (1999). A Proposition on Floating Gate Neuron MOS Macromodeling for Device Fabrications (Special Section on VLSI Design and CAD Algorithms). IEICE Transactions on Fundamentals of Electronics Communications and Computer Sciences. 82(11). 2485–2491. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact